Business
Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative
About this update from Sight Sciences, Inc.
[{"type":"text","content":"MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that data from clinical studies of the OMNI® Surgical System will be presented at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. Additionally, the Company is sponsoring a minimally invasive glaucoma surgery (MIGS) education symposium. The conference will take place April 22-26, 2022 at the Walter E. Washington Convention Center in Washington, D.C. Poster/Paper Presentations: Three posters have been accepted for presentation. Details of the presentations are as follows: Session Title: “Outcomes of Canaloplasty and Trabeculotomy in Eyes with Previous Trabecular Micro-Bypass Implantation”Presenter: Arkadiy Yadgarov, MD, ABO; Anita Campbell, MD, ABOLocation: WEWCCDate and Time: Friday, April 22; 8:45-8:50 AM ET Session Title: “IOP Fluctuations and Visual Field Status: Fluctuation Suppression with Combined Canaloplasty and Trabeculotomy in Open-Angle Glaucoma”Presenter: Mark F. Pyfer, MD, FACS; Brandon J. Baartman, MD; Inder P. Singh, MDLocation: WEWCC – Level 1, 143BDate and Time: Saturday, April 23; 8:51-8:56 AM ET Session Title: “Canaloplasty and Trabeculotomy Ab Interno Combined with Cataract Surgery: 12-Month Outcomes in Hispanic Patients with Open-Angle Glaucoma”Presenter: Mark J. Gallardo, MDLocation: WEWCC – Level 1, 144BDate and Time: Monday, April 25; 2:08-2:13 PM ET Event: Sight Sciences will host an educational symposium, “MIGS Beyond Cataract Surgery: An Interventional Mindset” moderated by Thomas Samuelson, MD, former president of ASCRS, on Friday, April 22 at 6:00 pm ET. The program will include a clinical discussion and interactive Q&A session featuring the OMNI® Surgical System and highlighting the benefits of stent-free MIGS. Registration is available here. About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance pat...